Barclays PLC Meira G Tx Holdings PLC Transaction History

Barclays PLC

$353 Billion
Q1 2025

A detailed history of Barclays PLC transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Barclays PLC holds 83,765 shares of MGTX stock, worth $438,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,765

Previous 147,755 43.31%

Holding current value

$438,928

Previous $899,000 36.82%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$5.71 - $8.25 $365,382 - $527,917	-63,990 Reduced 43.31%	83,765 $568,000
Q4 2024 Feb 13, 2025	SELL	$4.03 - $7.1 $290 - $511	-72 Reduced 0.05%	147,755 $899,000
Q3 2024 Nov 15, 2024	BUY	$3.88 - $5.23 $296,575 - $399,765	76,437 Added 107.07%	147,827 $618,000
Q2 2024 Aug 14, 2024	SELL	$4.21 - $5.81 $22,603 - $31,193	-5,369 Reduced 6.99%	71,390 $300,000
Q1 2024 May 15, 2024	SELL	$5.78 - $7.33 $126,541 - $160,475	-21,893 Reduced 22.19%	76,759 $465,000
Q4 2023 Feb 15, 2024	BUY	$3.6 - $7.15 $112,741 - $223,916	31,317 Added 46.51%	98,652 $693,000
Q3 2023 Nov 07, 2023	SELL	$4.79 - $7.19 $3,530 - $5,299	-737 Reduced 1.08%	67,335 $331,000
Q2 2023 Aug 03, 2023	SELL	$5.19 - $8.07 $74,902 - $116,466	-14,432 Reduced 17.49%	68,072 $457,000
Q1 2023 May 04, 2023	BUY	$5.04 - $8.6 $43,182 - $73,684	8,568 Added 11.59%	82,504 $426,000
Q4 2022 Feb 13, 2023	BUY	$5.8 - $8.98 $151,275 - $234,216	26,082 Added 54.5%	73,936 $482,000
Q3 2022 Nov 03, 2022	SELL	$7.55 - $11.25 $1,781 - $2,655	-236 Reduced 0.49%	47,854 $403,000
Q2 2022 Aug 12, 2022	BUY	$6.8 - $14.23 $44,723 - $93,590	6,577 Added 15.84%	48,090 $364,000
Q1 2022 May 16, 2022	SELL	$13.42 - $23.38 $238,943 - $416,280	-17,805 Reduced 30.02%	41,513 $575,000
Q4 2021 Feb 14, 2022	BUY	$12.78 - $23.74 $10,390 - $19,300	813 Added 1.39%	59,318 $1.41 Million
Q3 2021 Nov 09, 2021	BUY	$11.73 - $16.08 $97,910 - $134,219	8,347 Added 16.64%	58,505 $772,000
Q2 2021 Aug 13, 2021	SELL	$12.85 - $16.2 $54,188 - $68,315	-4,217 Reduced 7.76%	50,158 $778,000
Q1 2021 May 13, 2021	BUY	$13.84 - $17.8 $134,414 - $172,873	9,712 Added 21.75%	54,375 $785,000
Q4 2020 Feb 11, 2021	BUY	$12.4 - $17.6 $298,282 - $423,368	24,055 Added 116.73%	44,663 $676,000
Q3 2020 Nov 12, 2020	SELL	$11.59 - $14.93 $21,731 - $27,993	-1,875 Reduced 8.34%	20,608 $274,000
Q2 2020 Aug 12, 2020	BUY	$11.79 - $15.97 $162,926 - $220,689	13,819 Added 159.5%	22,483 $283,000
Q1 2020 May 13, 2020	SELL	$9.31 - $21.24 $80,242 - $183,067	-8,619 Reduced 49.87%	8,664 $117,000
Q4 2019 Feb 10, 2020	BUY	$13.91 - $21.48 $1,613 - $2,491	116 Added 0.68%	17,283 $346,000
Q3 2019 Nov 14, 2019	BUY	$15.84 - $30.01 $633 - $1,200	40 Added 0.23%	17,167 $274,000
Q2 2019 Aug 14, 2019	BUY	$17.38 - $26.88 $162,155 - $250,790	9,330 Added 119.66%	17,127 $461,000
Q1 2019 May 15, 2019	BUY	$9.2 - $21.21 $71,732 - $165,374	7,797 New	7,797 $135,000
Q4 2018 Feb 14, 2019	SELL	$9.61 - $14.02 $13,309 - $19,417	-1,385 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$8.1 - $13.6 $11,218 - $18,836	1,385 New	1,385 $19,000

Others Institutions Holding MGTX

# of Institutions

119

Shares Held

47.3M

Call Options Held

159K

Put Options Held

38.4K

View Full List

About MeiraGTx Holdings plc

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $236M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

More about MGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account